Skip to main content

Table 1 Clinicopathological characteristics of the testicular germ cell tumor cohort

From: m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance

Clinicopathological features

TGCT patients (n = 122)

Median age, years (IQR)

28 (24–36)

Histological type

 Seminoma

56/122 (45.9%)

 Embryonal carcinoma

5/122 (4.1%)

 Postpubertal-type yolk sac tumor

0/122 (0%)

 Choriocarcinoma

0/122 (0%)

 Postpubertal-type teratoma

3/122 (2.5%)

 Mixed tumor

58/122 (47.5%)

Pathological stage

 I

78/122 (63.9%)

 II

23/122 (18.9%)

 III

21/122 (17.2%)

IGCCCG grouping (for metastatic disease)

 Good

31/44 (70.5%)

 Intermediate

6/44 (13.6%)

 Poor

7/44 (15.9%)

Clinicopathological features

Primary TGCT tumor samples (n = 197)

Histological type

 Seminoma

75/197 (38.0%)

 Embryonal Carcinoma

39/197 (19.8%)

 Postpubertal-type yolk sac tumor

35/197 (17.8%)

 Choriocarcinoma

12/197 (6.1%)

 Postpubertal-type teratoma

36/197 (18.3%)

Clinicopathological features

Metastatic TGCT tumor samples (n = 19)

Histological type

 Seminoma

1/19 (5.3%)

 Embryonal carcinoma

5/19 (26.3%)

 Postpubertal-type yolk sac tumor

3/19 (15.8%)

 Choriocarcinoma

1/19 (5.3%)

 Postpubertal-type teratoma

9/19 (47.3%)

Type of metastasis

 Lymph node

12/19 (63.2%)

 Visceral

7/19 (36.8%)

  1. IGCCCG International Germ Cell Cancer Collaborative Group, IQR interquartile range, TGCT testicular germ cell tumors